Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity. Breadcrumbs UL Home Research Publications Year of Publication 2013 Journal American Journal Of Pathology DOI 10.1016/j.ajpath.2013.06.029
